Abstract
While a dominant inheritance of breast cancer (vertical inheritance) is well known, less is known about a possible recessive inheritance (horizontal inheritance). In a clinical series of 1676 breast cancer patient’s family history was scored as vertical (grandmother-aunt-mother-sister-daughter) or horizontal (sister-sister) and related to histopathological tumor type, presence of germline mutations, bilaterality, multifocality, screening, parity, hormone replacement therapy (HRT) use and age at diagnosis. Prognosis was estimated by also adding tumor size, lymph node status, distant metastases and hormone receptor status at diagnosis into a Cox proportional hazard model. Excluding mutations carriers, a horizontal family history (5% of all cases) was significantly associated with tubular tumor type [OR = 3.87(1.44–10.41)]. A vertical family history (23% of all cases) was significantly related to tumor multifocality [OR = 2.30(1.51–3.50)], tumor bilaterality [OR = 2.08(1.44–3.00)] and screening detection [OR = 1.50(1.10–2.05)]. No significant difference in survival could be seen between patients with none, horizontal or vertical family history. However, germline mutation carriers (BRCA1/2, TP53 or CDKN2A, present in 0.95% of the cases) had a significantly worse survival. Screening detected cases, HRT ever users and patients with estrogen receptor positive tumors had a significantly better survival adjusting for age at diagnosis, tumor size, lymph node status and presence of distant metastases at diagnosis. Factors associated with a horizontal family history were found, defining a possible phenotype for a recessive inheritance: tubular breast cancer.
Similar content being viewed by others
Abbreviations
- HRT:
-
Hormone replacement therapy
- OR:
-
Odds ratio
- CI:
-
Confidence intervals
- HR:
-
Hazard ratio
- ER:
-
Estrogen receptor
- PgR:
-
Progesterone receptor
- LCIS:
-
Lobular carcinoma in situ
- DCIS:
-
Ductal carcinoma in situ
- BC:
-
Breast cancer
References
O’Brien JM (2000) Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland, by P. Lichtenstein, N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe, and K. Hemminki. N Engl J Med 343:78–84, 2000. Surv Ophthalmol 45(2):167–168
Peto J, Mack TM (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26(4):411–414
Easton DF (1999) How many more breast cancer predisposition genes are there? Breast Cancer Res 1(1):14–17
Ripperger T, Gadzicki D, Meindl A, Schlegelberger B (2009) Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet 17(6):722–731
Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40(1):17–22
Athma P, Rappaport R, Swift M (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92(2):130–134
Goldstein AM, Amos CI (1990) Segregation analysis of breast cancer from the cancer and steroid hormone study: histologic subtypes. J Natl Cancer Inst 82(24):1911–1917
Amos CI, Goldstein AM, Harris EL (1991) Familiality of breast cancer and socioeconomic status in blacks. Cancer Res 51(7):1793–1797
Ciske DJ, Rich SS, King RA et al (1996) Segregation analysis of breast cancer: a comparison of type-dependent age-at-onset versus type-dependent susceptibility models. Genet Epidemiol 13(4):317–328
Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21(1):1–18
Kaufman DJ, Beaty TH, Struewing JP (2003) Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes. Cancer Epidemiol Biomarkers Prev 12(10):1045–1052
Anderson E, Berg J, Black R et al (2008) Predicting breast cancer risk: implications of a “weak” family history. Fam Cancer 7(4):361–366
Olsson HL (2009) Lobular breast carcinoma as a possible candidate phenotype for recessively inherited breast cancer. Cancer Res 69(2):119S–S
Li CI, Daling JR, Malone KE et al (2006) Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 15(5):946–954
Lagios MD, Rose MR, Margolin FR (1980) Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma. Am J Clin Pathol 73(1):25–30
Jernstrom H, Frenander J, Ferno M, Olsson H (1999) Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients. Br J Cancer 80(9):1453–1458
Brinton LA, Richesson D, Leitzmann MF et al (2008) Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev 17(11):3150–3160
Tabar L, Dean PB (2003) Mammography and breast cancer: the new era. Int J Gynaecol Obstet 82(3):319–326
Acknowledgments
The study has been supported by grants from the Swedish Cancer Society, The Swedish Research Council, The Hospital Funds of the Lund University Hospital, and Regional Research Funds in Skane.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ellberg, C., Jönsson, G. & Olsson, H. Can a phenotype for recessive inheritance in breast cancer be defined?. Familial Cancer 9, 525–530 (2010). https://doi.org/10.1007/s10689-010-9355-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-010-9355-4